Related Experiment Video

Updated: May 9, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Elafin: a possible new biomarker and immunohistochemical stain for pre-engraftment syndrome

Anna H Chacon, Uzma Farooq, Michael I Shiman

    Journal of the American Academy of Dermatology
    |July 23, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

    An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

    Published on: July 20, 2014

    Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM)11:02

    Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM)

    Published on: January 23, 2015

    Related Concept Videos

    Enzyme-Linked Immunosorbent Assay01:33

    Enzyme-Linked Immunosorbent Assay

    In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
    There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.